Search

Headquarters

Contact Us

  • (+01) 512 835 8026
  • info@myriadrbm.com
  • 3300 Duval Road
    Austin, TX 78759
    USA
  • Mon to Fri - 8:50am to 5:00pm

Ready to order?

Great! Every order starts with a quote.

Get Started

  • (+01) 512 835 8026
  • info@myriadrbm.com
Get a Quote Contact | FAQ's | Blog
Myriad RBM Myriad RBM

Innovative Biomarker Solutions

Toggle menu

Skip to content
  • About Us
    • About Myriad RBM

      Myriad RBM’s CLIA certified biomarker testing laboratory, is located in Austin, TX. Myriad RBM is a wholly owned subsidiary of Myriad Genetics, Inc. (MYGN), a leading molecular diagnostic company based in Salt Lake City, Utah which develops and markets novel predictive medicine, personalized medicine and prognostic medicine tests.
    • About Myriad RBM

      • About Us
      • Management
      • Quality Policy
      • Employment
      • Partners
      • Sales Team
      • Certifications
    • Newsroom

      • Press
      • Company Newsletters
      • Conferences
      • Abstracts + Papers
      • Sign Up for Our Newsletter
      • Blog
    • Data Quality

      • Overview
      • Myriad RBM Technology
  • Biomarker Solutions
    • Solutions

      • Overview
      • Assay Change Log

      CustomMAP

      If a smaller, more focused panel of analytes is required, we can build a Custom MAP to meet your needs.

      Learn More »

      TruCulture Spike

    • Multiplexed Immunoassays

      • Full Biomarker Menu
      • DiscoveryMAP® v. 4.0
      • ExplorerMAP™ v. 1.0
      • HumanMAP® v. 2.0
      • CardiovascularMAP® v. 3.0
      • AngiogenesisMAP® v. 1.0
      • InflammationMAP® v. 1.1
      • ImmunoMAP® v. 1.0
      • MetabolicMAP® v. 1.0
      • KidneyMAP®
      • CytokineMAP A
      • CytokineMAP B
      • SARS-CoV-2/COVID-19 Research
      • Cytokine Storm Testing for SARS-CoV-2/COVID-19 Research
      • SARS-CoV-2 Multiplex Serology
      Webinar Registration
    • TruCulture

      Whole Blood Collection and Culture System

      Learn More »
      Quanterix simoa

      Ultrasensitive immunoassays manufactured by Myriad RBM and based on Quanterix’s Simoa technology.

      Learn More »
  • Resources + Support
    • Resources

      • Bibliography
      • White Papers
      • Application Notes
      • Events
      • Webinars
      • Blog
      • COVID-19/SARS-CoV-2 Research Tools
    • Support

      • Client Services
      • Request a Biomarker
      • Speak to a Scientist
  • How to Order
    • Ordering Information

      • How to Order
      • Request a quote
      • Acceptable Samples
      • Frequently Asked Questions
    • Request Information

      • Contact Client Services
      • Request a Biomarker
      • Speak to a Scientist
    • Ready to Order?

      Great!

      Every order starts with a quote.

      Get Started

  •  

Category Archives: Blog

10 Jun 2013

Biomarker Reliability and Disease Characteristics

June 10, 2013
Desiree Klingler-Gaston
Blog
Proper study design is one of the most important aspects of successful biomarker discovery and that includes both a thorough understanding of the dise...
Read More
30 May 2013

Swedish universities identify a prognostic protein biomarker for bladder cancer

May 30, 2013
myriadrbm
Blog, Cancer
Research published in the British Journal of Cancer correlates membranous expression of PODXL in urothelial bladder cancer with unfavorable tumor char...
Read More
23 May 2013

Blood Protein May Contribute to Early Development of Atherosclerosis

May 23, 2013
Desiree Klingler-Gaston
Blog, Cardiac
A study conducted by Dr. Eric Thorin of the Montreal Heart Institute, suggests blood levels of angiopoietin-like protein 2 (angptl2) may represent an...
Read More
22 May 2013

Webinar: Translating Preclinical Pharmacology in Clinical Activity

May 22, 2013
Desiree Klingler-Gaston
Blog, Inflammation, Utilized Myriad RBM's Services
Download this webinar to learn how Myriad RBM's products and services were used by VentiRx to compare potency, define PK/PD relationships, identify po...
Read More
23 Apr 2013

T-DM1 Most Effective for Aggressive HER2-Positive Breast Cancer

April 23, 2013
myriadrbm
Blog, Cancer
A study presented at this month's American Association for Cancer Research annual meeting by Jose Baselga, M.D., Ph.D., suggests that tumor levels of...
Read More
21 Mar 2013

Metabolic Biomarker Associated with Migraine Severity

March 21, 2013
Desiree Klingler-Gaston
Blog, Neuroscience and Neurological
Migraines, severe headaches that last for greater than four hours, are often characterized by specific symptoms such as nausea, sensitivity to light a...
Read More
14 Mar 2013

New Blood-Based Biomarker Assay for the Early Detection of Kidney Cancer

March 14, 2013
Desiree Klingler-Gaston
Blog, Renal Function and Toxicity
Researchers identified a 3-biomarker immunoassay, measuring NNMT, LCP1, and NM23A, that successfully distinguishes healthy patients from those with re...
Read More
1 … 10 11 12 13 14 … 20

Categories

  • Biomarkers (4)
  • Blog (134)
    • Autoimmune and Arthritis (10)
    • Cancer (28)
    • Cardiac (9)
    • Cytokines and Chemokines (20)
    • Diabetes (7)
    • Gastrointestinal (1)
    • Inflammation (42)
    • Neuroscience and Neurological (33)
    • News From the Lab (1)
    • Renal Function and Toxicity (8)
    • Technology- Multi-Analyte Profile (1)
    • TruCulture (2)
  • COVID-19 (1)
  • Press (37)
  • Utilized Myriad RBM's Services (43)

ABOUT MYRIAD RBM

Overview
Management
Quality Policy
Employment
Partners
Sales Team
Certifications

MAPs

Full Biomarker Menu
DiscoveryMAP® v. 3.3
ExplorerMAP™ v. 1.0
HumanMAP® v. 2.0
CardiovascularMAP® v. 3.0
AngiogenesisMAP® v. 1.0
InflammationMAP® v. 1.0
ImmunoMAP® v. 1.0
NeuroMAP™ v. 1.0
MetabolicMAP® v. 1.0
KidneyMAP®
CytokineMAP A
CytokineMAP B

RESOURCES

Bibliography
White Papers
Events
Webinars
Blog

SUPPORT

Customer Support
Speak to a Scientist
Assay Change Log
Request a Biomarker
FAQs

SOLUTIONS

Results Processing
Assay Development
Quality Control
Project Management

SERVICES

Multiplexed Assay Services
Ultrasensitive Assays
TruCulture

  • Jobs
  • Terms of Use
  • Privacy Practice
  • Analytes Listing
Copyright © 2021 Myriad RBM. All rights reserved. Myriad does not sell your personal information